mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.2 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.2 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.037 |
0.2 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.2 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.2 |